High Mark Wealth Management LLC Ultragenyx Pharmaceutical Inc. Transaction History

High Mark Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$73.71 - $87.86 $15,405 - $18,362	-209 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$77.92 - $102.4 $8,804 - $11,571	113 Added 117.71%	209 $19,000
Q2 2021 Aug 02, 2021	BUY	$92.19 - $115.71 $1,198 - $1,504	13 Added 15.66%	96 $9,000
Q1 2021 Apr 22, 2021	SELL	$106.9 - $167.73 $4,169 - $6,541	-39 Reduced 31.97%	83 $9,000
Q4 2020 Jan 27, 2021	SELL	$84.4 - $177.39 $50,724 - $106,611	-601 Reduced 83.13%	122 $17,000
Q3 2020 Oct 26, 2020	BUY	$72.98 - $90.0 $45,393 - $55,980	622 Added 615.84%	723 $59,000
Q2 2020 Jul 22, 2020	BUY	$46.91 - $78.22 $4,737 - $7,900	101 New	101 $8,000

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.99B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on High Mark Wealth Management LLC with notifications on news.